OR WAIT null SECS
January 17, 2023
Renewed interest in psychedelic research shows great promise for patients in need of more effective therapies.
December 14, 2022
Kenneth Koblan, PhD, chief scientific officer at Sunovion, discusses novel therapy development and clinical trial challenges in mental health.
December 02, 2022
Nabil Chehab, medical affairs head of lung cancer franchise at AstraZeneca, discuss strategies used in the Phase III AEGEAN trial for treating non-small lung cancer (NSCLC).
October 31, 2022
Richard Williams, PhD, chief medical officer at Kinnate Biopharma Inc. discusses clinical trial strategies and challenges.
October 14, 2022
Pursuing new tools and capabilities in sample logistics, storage, and data analysis.
Approaches sponsors, CROs, and investigators can take from the DMD experience.
As activity in this space grows, so do the hurdles in moving these products forward.
August 08, 2022
Industry now leveraging reporting system to empower patients and improve research.
July 13, 2022
Why oncology needs dosing redesign.
July 12, 2022
Pandemic has brought new sense of awareness to respiratory diseases and clinops.